表紙
市場調査レポート

医療機器におけるPE/VC活動:小規模医療機器メーカーへのPE/VC投資件数が過去4年で増加

PE/VC Activity in Medical Devices - Number of PE/VC Investments in Small Sized Medical Devices Companies has Increased in the Past Four Years

発行 GBI Research 商品コード 203109
出版日 ページ情報 英文 90 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
医療機器におけるPE/VC活動:小規模医療機器メーカーへのPE/VC投資件数が過去4年で増加 PE/VC Activity in Medical Devices - Number of PE/VC Investments in Small Sized Medical Devices Companies has Increased in the Past Four Years
出版日: 2011年07月01日 ページ情報: 英文 90 Pages
概要

2010年には、769件のプライベートエクイティ(PE)およびベンチャーキャピタル(VC)財務取引が行われ、2009年の556件から増加しました。2010年は体外診断薬、心血管装置、医療用ITが主な投資先となり、それぞれ20%、13%、10%のシェアとなりました。2007〜2010年のPE/VCの大半は1,000万米ドル以下のものですが、継続的な技術革新によって、今後も医療機器市場は安定した成長が見込まれています。

当レポートでは、医療機器業界における(PE)およびベンチャーキャピタル(VC)契約動向について調査し、2007〜2010年の動向、各社の撤退・打ち切り動向、欧米およびアジアの地域別概要、セグメント別の契約動向などをまとめ、概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション

第3章 医療機器業界におけるPE/VC契約サマリー

  • 契約件数と契約額:2007〜2010年
  • 段階別セグメンテーション:2007〜2010年
  • 撤退・打ち切り
    • Ion Beam ApplicationsがBioAssays Unitの販売を打ち切り
    • Smiths GroupがSmiths Medical向けApax Partnersの入札を拒否
    • Ares Life Sciences、Essex、Intesa、AlphaがSorinの買収を打ち切り
    • AMICASがThoma Bravoの買収を打ち切り
    • Q-MedがIvytanによる買収申し入れを打ち切り
    • EndologixがElliot Associatesによる買収申し入れを打ち切り

第4章 地域別医療機器のPE/VC契約

  • 北米
  • 欧州
  • アジア太平洋地域

第5章 市場別医療機器のPE/VC契約

  • 体外診断薬
  • 心血管装置
  • 整形外科装置
  • 麻酔・呼吸器系装置
  • 歯科装置
  • 糖尿病ケア装置
  • 画像診断
  • ドラッグデリバリー装置
  • 内視鏡装置
  • 耳鼻咽喉科装置
  • 医療用IT
  • 病院備品
  • 腎臓・泌尿器科装置
  • 神経科装置
  • 眼科装置
  • 患者モニタリング
  • 手術装置
  • 創傷ケア管理

第6章 トップ財務アドバイザー

第7章 付録

図表

目次
Product Code: GBIME0033MR

Summary

GBI Research’s report, “PE/VC Activity in Medical Devices - Number of PE/VC Investments in Small Sized Medical Devices Companies has Increased in the Past Four Years” provides key data, information and analysis on the global medical devices market. The report provides private equity and venture capital (PE/VC) activity in 18 medical device market categories - In Vitro Diagnostics, Cardiovascular Devices, Orthopedic Devices, Anesthesia and Respiratory Devices, Dental Devices, Diabetes Care devices, Diagnostic Imaging, Drug Delivery Devices, Endoscopy Devices, Ear, Nose and Throat Devices, Healthcare IT, Hospital Supplies, Nephrology and Urology, Neurology Devices, Ophthalmic Devices, Patient Monitoring, Surgical Equipment and Wound Care Management. The report provides comprehensive information on the factors affecting PE/VC investment in these categories. The report also reviews the detailed analysis of the PE/VC deals worth greater than $100m in each category. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

• Key geographies covered include North America, Europe and the Asia-Pacific.
• PE/VC activity in the following market categories - In Vitro Diagnostics, Cardiovascular Devices, Orthopedic Devices, Anesthesia and Respiratory Devices, Dental Devices, Diabetes Care devices, Diagnostic Imaging, Drug Delivery Devices, Endoscopy Devices, ENT Devices, Healthcare IT, Hospital Supplies, Nephrology and Urology, Neurology Devices, Ophthalmic Devices, Patient Monitoring, Surgical Equipment and Wound Care Management
• PE/VC deals from 2007 to 2010 in the medical device market and detailed analysis of deals greater than $100m in size.
• The report also covers top financial advisors for the PE/VC deals from 2007 to 2010 in the medical device market.

Reasons to buy

• Develop business strategies by understanding the trends and developments that are driving the medical devices market globally.
• Design and develop your product development, marketing and sales strategies.
• Exploit PE/VC opportunities by identifying market players with the most innovative pipeline.
• Develop market-entry and market expansion strategies.
• Identify key players best positioned to take advantage of the emerging market opportunities.
• Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return.
• What’s the next big thing in the PE/VC activity in medical devices landscape? Identify, understand and capitalize.
• Make more informed business decisions from the insightful and in-depth analysis of the global medical devices market and the factors shaping it.

Executive Summary

GBI Research’s report, “PE/VC Activity in Medical Devices - Number of PE/VC Investments in Small Sized Medical Devices Companies Has Increased in the Past Four Years” provides key data, information and analysis on the global medical devices market. The report provides private equity and venture capital (PE/VC) activity in 18 medical device market categories - In Vitro Diagnostics, Cardiovascular Devices, Orthopedic Devices, Anesthesia and Respiratory Devices, Dental Devices, Diabetes Care devices, Diagnostic Imaging, Drug Delivery Devices, Endoscopy Devices, Ear, Nose and Throat Devices, Healthcare IT, Hospital Supplies, Nephrology and Urology, Neurology Devices, Ophthalmic Devices, Patient Monitoring, Surgical Equipment and Wound Care Management. The report provides comprehensive information on the factors affecting PE/VC investment in these categories. The report also reviews the detailed analysis of the PE/VC deals worth greater than $100m in each category. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

In Vitro Diagnostics (IVD), Cardiovascular Devices and Healthcare IT Markets Attracted the Most PE/VC Investments in 2010

Medical Devices Industry, Global, PE/VC Deals (%), 2010

Source: GBI Research, Company Annual Reports and Press Releases

A total of 769 private equity (PE) and venture capital (VC) financing deals took place in 2010, compared to 556 in 2009. In 2010, the in vitro diagnostics (IVD), cardiovascular devices and healthcare IT markets attracted the most PE/VC investments, with shares of 20%, 13% and 10% respectively. Within the IVD devices categories, it is the immunochemistry and clinical chemistry categories that are gaining investor attention. In the cardiovascular devices market, it is interventional cardiology that has proved attractive. In interventional cardiology, minimally invasive techniques are being widely chosen by the patient population, thus resulting in the uptake of catheter approaches for congestive heart failure, mitral valve repair and the next generation stents. Large companies are showing an interest and investing in the research and development (R&D) of minimally invasive techniques to treat coronary artery disease and valve repair. The other major categories that received PE/VC investor attention were orthopedic devices, surgical equipment and diagnostic imaging.

In addition, there is a growing awareness regarding the use of information technology (IT) in healthcare to maintain efficient and productive use of the available resources. There is a growing investment in the healthcare IT and IVD markets due to increasing advancements and awareness of the use of IT services to maintain an efficient and effective healthcare system. The increase in the diseased population has led to development of diagnostic devices more capable of detecting diseases with ease and accuracy. Moreover, PE/VC firms look for startup companies with promising technologies to invest in.

PE/VC Investment in Start-up Firms was the Predominant Strategy that Investors Followed in 2010

Medical Devices Industry, Global, PE/VC Deals, Deals by Company Stages (%), 2010

Source: GBI Research, Company Annual Reports and Press Releases

In 2010, the various stages of medical devices companies in which PE/VC funding was aimed at start-up medical device firms with 53% of the total 769 deals. The second most adopted strategy for investment was in the expansion stage, with 21%, followed by later stage investments, with 16%. PE/VC funding was adopted by investors and medical device companies to give high speed access to new advanced technologies and avoid barriers to entry, expand their portfolio of products and to improve their asset valuations. From 2007-2010, PE/VCs increased their financial investments in the medical device market because of the apparent high potential of the North American and European healthcare sectors. VC firms invest in early-stage companies with high potential for future growth. Similarly, PE firms invest in start-ups, and help them to streamline their operations. Start-up companies in medical devices are started by innovators who have little knowledge or experience of entrepreneurship. PE/VCs help these companies by providing adequate management support. However, these firms invest with an intention of profitable exits from their investments. The biggest exit strategies for PE/VCs are public offerings or acquisitions by other bigger companies. Startup firms are more focused on developing new technologies and work on ways of commercializing technology. Therefore, PE/VC investment is being increasingly seen in start-up firms.

The Majority of PE/VC Financing in Medical Devices that Took Place from 2007 to 2010 were of Deal Value Less than $10m

The majority of PE/VC funding for the medical devices industry from 2007 to 2010 was for deal values of less than $10m. The medical equipment market offers strong growth prospects and is highly regulated and driven by constant technological innovation. The two largest markets for medical equipment are the US and European Union (EU). The recent trends for financing have undergone a significant change due to the changing scenario worldwide. Out of the various options available, investors are financing more in start-up firms. The medical device industry is highly fragmented and the need for new technological innovation is huge. There are many small players with annual revenues of less than $5m. Small innovative firms are associated with developing new medical technology products. Most of these organizations specialize in only one technology and much redundancy exists between companies. Start-up firms in medical device companies are groomed by investors so that they can be acquired by larger companies. Small firms, after receiving US FDA marketing approval for their products, are targeted for acquisition by large medical equipment companies. There exists an advantage for both small and large firms. Small firms benefit from added resources, while large firms gain from advanced technologies. Therefore all these factors and the fiscal pressure of staying afloat are compelling many smaller firms to merge with larger ones.

North America is the Biggest Market for PE/VC Deals in Medical Devices Industry in 2010

Medical Devices Industry, Global, PE/VC Deals (%), 2007-2010

Source: GBI Research, Company Annual Reports and Press Releases

North America is one of the biggest markets for PE/VC investment in medical devices. Between 2007 and 2010, the targets for medical device PE/VC deals were concentrated heavily in the US, Canada, Europe and the Asia-Pacific. The US is the most attractive venue for PE/VC deals in the global medical devices industry due to a higher concentration of companies with key products and technologies in the development stage. A robust research program, considerable public and private funding opportunities, the protection of intellectual property, ample infrastructure and public entrepreneurship programs have created the perfect mix for medical technology innovation in the US.

Table of Contents

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 9
2.1 GBI Research Report Guidance 9
3 PE/VC Deals Summary in the Medical Device Industry 10
3.1 PE/VC Deals by Number and Deal Value, 2007-2010 10
3.2 Segmentation of PE/VC Deals by Stages, 2007-2010 11
3.2.1 Conclusion 12
3.3 Withdrawn/Terminated Deals 12
3.3.1 Ion Beam Applications Terminated Sale of Its BioAssays Unit 13
3.3.2 Smiths Group Rejects Cash Bid of Apax Partners for Smiths Medical 13
3.3.3 Ares Life Sciences, Essex, Intesa and Alpha Terminated Acquisition of Sorin 14
3.3.4 AMICAS Terminated Acquisition with Thoma Bravo 14
3.3.5 Q-Med Terminated Offer for Its Acquisition by Ivytan 15
3.3.6 Endologix Terminated Offer for Its Acquisition by Elliot Associates 15
3.3.7 Conclusion 16
4 PE/VC Deals in Medical Devices by Geography 17
4.1 PE/VC Deals in North America 17
4.2 PE/VC Deals in Europe 19
4.3 PE/VC Deals in the Asia-Pacific 21
4.3.1 Conclusion 22
5 PE/VC Activity in Medical Devices by Market 23
5.1 In Vitro Diagnostics 23
5.1.1 Deals Analysis 24
5.1.2 PE/VC Deals - In Vitro Diagnostics 24
5.1.3 Pacific Biosciences Secured Additional $59m in Series F Round of Financing 25
5.1.4 Legal & General Ventures Sells LGC to Bridgepoint 25
5.1.5 Welsh, Carson, Anderson & Stowe Acquired Spectrum Laboratory Network from Apax Partners 26
5.1.6 Bridgepoint Capital Acquired Terveystalo Healthcare 27
5.1.7 Duke Street Acquired Biomnis 27
5.1.8 The EQT V fund Acquired Dako Denmark 28
5.2 Cardiovascular Devices 29
5.2.1 Deal Analysis 30
5.2.2 Ares Life Sciences Acquired Stake in Esaote 30
5.2.3 Boston Scientific Sells Fluid Management and Venous Access Businesses To Avista Capital 31
5.2.4 Cardionet Secures $110m in Series E Financing 32
5.3 Orthopedic Devices 33
5.3.1 Deals Analysis 34
5.3.2 Small Bone Innovations Secured $108m in Series D Financing 36
5.3.3 Globus Medical Secures $110m Series E Financing 36
5.4 Anesthesia and Respiratory Devices 38
5.4.1 Deals Analysis 39
5.4.2 Water Street Healthcare Acquires Stake in CareCentrix from Gentiva Health 39
5.5 Dental Devices 40
5.5.1 Deals Analysis 41
5.5.2 TA Associates Acquired Stake in Amann Girrbach 41
5.5.3 Palamon Capital Partners Completes Acquisition of Associated Dental Partners 42
5.6 Diabetes Care Devices 43
5.6.1 Deals Analysis 44
5.6.2 The Blackstone Group Acquires Apria Healthcare 44
5.7 Diagnostic Imaging 45
5.7.1 Deals Analysis 46
5.7.2 Bridgepoint Capital Acquired Terveystalo Healthcare 46
5.7.3 Merrill Lynch and Ares Acquires Euromedic from Warburg Pincus 47
5.7.4 Avista Capital Partners Acquired Bristol-Myers Squibb Medical Imaging 48
5.7.5 Dubai International Capital Acquired Alliance Medical from Bridgepoint Capital 48
5.7.6 DeA Capital and Mediobanca Acquired 53% Majority Stake in Generale de Sante 49
5.8 Drug Delivery Devices 50
5.8.1 Deals Analysis 51
5.8.2 Warburg Pincus Acquired Lifecore Biomedical 51
5.9 Endoscopy Devices 52
5.9.1 Deals Analysis 53
5.9.2 TPG Capital Acquires Axcan Pharma 53
5.10 Ear, Nose and Throat (ENT) Devices 54
5.10.1 Deals Analysis 55
5.10.2 Technitrol Sells Medtech Component Business To Altor 55
5.11 Healthcare IT 56
5.11.1 Huntsman Gay Global Acquires 51% Stake in Sunquest Information from Vista Equity Partners 58
5.11.2 BC Partners and Silver Lake Acquires MultiPlan from the Carlyle Group and Welsh, Carson, Anderson & Stowe 58
5.11.3 OMERS Private Equity Completes Acquisition of Logibec Groupe Informatique 59
5.11.4 Francisco Partners Completes Acquisition Of Quadramed 60
5.11.5 ikaSystems Received Additional Investment From Essex Woodlands Health 61
5.11.6 Truveris Raises $3.8m in First Venture Financing Round 61
5.11.7 Glocal Healthcare Systems to Raise $3.25m in Venture Financing 62
5.11.8 Apax Partners, Bluecross Blueshield and Regence Group Acquired the TriZetto Group 62
5.11.9 Merrill Lynch and Ares Acquired Euromedic From Warburg Pincus 63
5.11.10 General Atlantic And Hellman & Friedman Acquires Remaining 48% Stake In Emdeon Business Services From HLTH 64
5.11.11 TA Associates Acquired Alere Medical 64
5.12 Hospital Supplies 66
5.12.1 Deals Analysis 67
5.12.2 The Blackstone Group Completes Acquisition of Polymer Group 67
5.12.3 EQT Partners Completed Acquisition of HTL-Strefa 68
5.12.4 Lehman Brothers Acquired Angelica 68
5.12.5 Tenet Healthcare Sells Its Majority Stake in Broadlane to TowerBrook Capital Partners 69
5.13 Nephrology and Urology Devices 70
5.13.1 Deals Analysis 71
5.13.2 Merrill Lynch and Ares Acquired Euromedic from Warburg Pincus 71
5.14 Neurology Devices 72
5.14.1 Deals Analysis 73
5.15 Ophthalmic Devices 73
5.15.1 3i Acquired Ultralase from Corporacion Dermoestetica 74
5.15.2 Warburg Pincus Acquired Bausch & Lomb 75
5.16 Patient Monitoring 76
5.16.1 Deals Analysis 77
5.16.2 TA Associates Acquired Alere Medical 77
5.17 Surgical Equipment 78
5.17.1 Deals Analysis 79
5.17.2 PerkinElmer Sells Illumination and Detection Solutions Business to Veritas Capital Fund Management 79
5.17.3 HLTH Sells Porex to Aurora Capital 80
5.18 Wound Care Management 81
5.18.2 Investor Acquired 34% Stake in Molnlycke Health Care 82
5.18.3 Nordic Capital Fund and Avista Capital Partners Acquire ConvaTec from Bristol-Myers Squibb 83
5.18.4 Investor and Morgan Stanley Completed Acquisition of Molnlycke Health Care from Apax Partners 84
6 Global Medical Devices, Top Financial Advisors 86
6.1 Top Financial Advisors, PE/VC Deals Medical Devices 86
7 PE/VC Activity in Medical Devices- Appendix 87
7.1 Acronyms 87
7.2 Research Methodology 88
7.2.1 Secondary Research 88
7.2.2 Primary Research 88
7.2.3 Models 89
7.2.4 Forecasts 89
7.2.5 Expert Panels 89
7.3 Contact Us 89
7.4 Disclaimer 90
7.5 Sources 90

List of Tables

Table 1: Medical Devices Market, Global, PE/VC, by Number of Deals and Deal Value, 2007-2010 10
Table 2: Medical Devices Industry, Global, PE/VC Deals, Number of Deals by Stages, 2007-2010 11
Table 3: Medical Devices Industry, Global, PE/VC Deals, Withdrawn/Terminated Deals, 2007-2010 12
Table 4: Medical Devices Industry, North America, PE/VC Deals, by Deal Volume and Deal Value ($m), 2007-2010 17
Table 5: Medical Devices, Europe, PE/VC Deals, by Deal Volume and Deal Value ($m), 2007-2010 19
Table 6: Medical Devices Industry, Asia-Pacific, PE/VC Deals, by Deal Volume and Deal Value ($m), 2007-2010 21
Table 7: In Vitro Diagnostics Market, Global, PE/VC, by Number of Deals, 2007-2010 23
Table 8: In Vitro Diagnostics Market, Global, PE/VC, by Deal Value ($m), 2007-2010 23
Table 9: In Vitro Diagnostics, Global, PE/VC Deals, 2007-2010 24
Table 10: Cardiovascular Devices Market, Global, PE/VCs, by Number of Deals, 2007-2010 29
Table 11: Cardiovascular Devices Market, Global, PE/VCs, by Deal Value ($m), 2007-2010 29
Table 12: Cardiovascular Devices, Global, PE/VC, 2007-2010 30
Table 13: Orthopedic Devices Market, Global, PE/VC, by Number of Deals, 2007-2010 33
Table 14: Orthopedic Devices Market, Global, PE/VC, by Deal Value ($m), 2007-2010 33
Table 15: Orthopedics Devices Market, Global, PE/VC, 2007-2010 35
Table 16: Anesthesia and Respiratory Devices Market, Global, PE/VC, by Number of Deals, 2007-2010 38
Table 17: Anesthesia and Respiratory Devices Market, Global, PE/VC, by Deal Value ($m), 2007-2010 38
Table 18: Anesthesia and Respiratory Devices Market, Global, PE/VC, by Volume, 2007-2010 39
Table 19: Dental Devices Market, Global, PE/VC, by Number of Deals, 2007-2010 40
Table 20: Dental Devices Market, Global, PE/VC, by Deal Value ($m), 2007-2010 40
Table 21: Dental Devices Market, Global, PE/VC, 2007-2010 41
Table 22: Diabetes Care Devices Market, Global, PE/VC, by Number of Deals, 2007-2010 43
Table 23: Diabetes Care Devices Market, Global, PE/VC, by Deal Value ($m), 2007-2010 43
Table 24: Diabetes Care Devices, Global, PE/VC, 2007-2010 44
Table 25: Diagnostic Imaging Market, Global, PE/VC, by Number of Deals, 2007-2010 45
Table 26: Diagnostic Imaging Market, Global, PE/VC, by Deal Value ($m), 2007-2010 45
Table 27: Diagnostic Imaging Market, Global, PE/VC, by Deal Value ($m), 2007-2010 46
Table 28: Drug Delivery Devices Market, Global, PE/VC, by Number of Deals, 2007-2010 50
Table 29: Drug Delivery Devices Market, Global, PE/VC, by Deal Value ($m), 2007-2010 50
Table 30: Drug Delivery Devices, Global, PE/VC, 2007-2010 51
Table 31: Endoscopy Devices Market, Global, PE/VC, by Number of Deals, 2007-2010 52
Table 32: Endoscopy Devices Market, Global, PE/VC, by Deal Value ($m), 2007-2010 52
Table 33: Endoscopy Devices Market, PE/VC, by Volume, Global, 2007-2010 53
Table 34: ENT Devices Market, Global, PE/VC, by Number of Deals, 2007-2010 54
Table 35: ENT Devices Market, PE/VC, by Deal Value ($m), Global, 2007-2010 54
Table 36: ENT Devices Market, Global, PE/VC, by Deal Volume, 2007-2010 55
Table 37: Healthcare IT Market, Global, PE/VC, by Number of Deals, 2007-2010 56
Table 38: Healthcare IT Market, Global, PE/VC, by Deal Value ($m), 2007-2010 56
Table 39: Healthcare IT Market, Global, PE/VC, by Deal Volume, 2007-2010 57
Table 40: Hospital Supplies Market, Global, PE/VC, by Number of Deals, 2007-2010 66
Table 41: Hospital Supplies Market, Global, PE/VC, by Deal Value ($m), 2007-2010 66
Table 42: Hospital Supplies Market, Global, PE/VC, by Deal Volume, 2007-2010 67
Table 43: Nephrology and Urology Devices Market, Global, PE/VC, by Number of Deals, 2007-2010 70
Table 44: Nephrology and Urology Devices Market, Global, PE/VC, by Deal Value ($m), 2007-2010 70
Table 45: Nephrology and Urology Devices Market, Global, PE/VC, by Deal Volume, 2007-2010 71
Table 46: Neurology Devices Market, Global, PE/VC, by Number of Deals, 2007-2010 72
Table 47: Neurology Devices Market, Global, PE/VC, by Deal Value ($m), 2007-2010 72
Table 48: Ophthalmic Devices Market, Global, PE/VC, by Number of Deals, 2007-2010 73
Table 49: Ophthalmic Devices Market, Global, PE/VC, by Deal Value ($m), 2007-2010 74
Table 50: Ophthalmic Devices Market, Global, PE/VC, by Deal Volume 2007-2010 74
Table 51: Patient Monitoring Devices Market, Global, PE/VC, by Number of Deals, 2007-2010 76
Table 52: Patient Monitoring Devices Market, Global, PE/VC, by Deal Value ($m), 2007-2010 76
Table 53: Patient Monitoring Devices Market, Global, PE/VC, by Deal Volume, 2007-2010 77
Table 54: Surgical Equipment Market, Global, PE/VC, by Number of Deals, 2007-2010 78
Table 55: Surgical Equipment Market, Global, PE/VC, Deal Value ($m), 2007-2010 78
Table 56: Surgical Equipment Market, Global, PE/VC, 2007-2010 79
Table 57: Wound Care Management Market, Global, PE/VC, by Number of Deals, 2007-2010 81
Table 58: Wound Care Management Market, Global, PE/VC, by Deal Value ($m), 2007-2010 81
Table 59: Wound Care Management, Global, PE/VC Deals, 2007-2010 82
Table 60: Medical Devices, Top Legal Advisors, 2007-2010 86

List of Figures

Figure 1: Medical Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010 10
Figure 2: Medical Devices Industry, Global, PE/VC Deals, Deals by Stages (%), 2007-2010 11
Figure 3: Medical Devices Industry, North America, PE/VC Deals, by Deal Volume and Deal Value ($m), 2007-2010 17
Figure 4: Medical Devices Industry, Europe, PE/VC Deals, by Deal Volume and Deal Value ($m), 2007-2010 19
Figure 5: Medical Devices Industry, Asia-Pacific, PE/VC Deals, by Deal Volume and Deal Value ($m), 2007-2010 21
Figure 6: In Vitro Diagnostics Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010 23
Figure 7: Cardiovascular Devices Market, Global, PE/VCs, by Number of Deals and Deal Value ($m), 2007-2010 29
Figure 8: Orthopedic Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010 33
Figure 9: Orthopedic Devices, Global, Pipeline Products Summary, 2010 34
Figure 10: Anesthesia and Respiratory Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010 38
Figure 11: Dental Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010 40
Figure 12: Diabetes Care Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010 43
Figure 13: Diagnostic Imaging Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010 45
Figure 14: Drug Delivery Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010 50
Figure 15: Endoscopy Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010 52
Figure 16: ENT Devices Market, PE/VC, Global, by Number of Deals and Deal Value ($m), 2007-2010 54
Figure 17: Healthcare IT Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010 56
Figure 18: Hospital Supplies Market, PE/VC, Global, by Number of Deals and Deal Value ($m), 2007-2010 66
Figure 19: Nephrology and Urology Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010 70
Figure 20: Neurology Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010 72
Figure 21: Ophthalmic Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010 73
Figure 22: Patient Monitoring Devices Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010 76
Figure 23: Surgical Equipment Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010 78
Figure 24: Wound Care Management Market, Global, PE/VC, by Number of Deals and Deal Value ($m), 2007-2010 81
Figure 25: Medical Devices, Global, PE/VC Deals, Top Financial Advisors, 2007-2010 86
Back to Top